Long-term influences of antihypertensive therapy on microalbuminuria in essential hypertension. 1994

L M Ruilope, and J M Alcázar, and E Hernández, and M Praga, and V Lahera, and J L Rodicio
Unidad de Hipertensión, Servicio de Nefrología, Hospital 12 de Octubre, Madrid, Spain.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D004232 Diuretics Agents that promote the excretion of urine through their effects on kidney function. Diuretic,Diuretic Effect,Diuretic Effects,Effect, Diuretic,Effects, Diuretic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000319 Adrenergic beta-Antagonists Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. Adrenergic beta-Antagonist,Adrenergic beta-Receptor Blockader,Adrenergic beta-Receptor Blockaders,beta-Adrenergic Antagonist,beta-Adrenergic Blocker,beta-Adrenergic Blocking Agent,beta-Adrenergic Blocking Agents,beta-Adrenergic Receptor Blockader,beta-Adrenergic Receptor Blockaders,beta-Adrenoceptor Antagonist,beta-Blockers, Adrenergic,beta-Adrenergic Antagonists,beta-Adrenergic Blockers,beta-Adrenoceptor Antagonists,Adrenergic beta Antagonist,Adrenergic beta Antagonists,Adrenergic beta Receptor Blockader,Adrenergic beta Receptor Blockaders,Adrenergic beta-Blockers,Agent, beta-Adrenergic Blocking,Agents, beta-Adrenergic Blocking,Antagonist, beta-Adrenergic,Antagonist, beta-Adrenoceptor,Antagonists, beta-Adrenergic,Antagonists, beta-Adrenoceptor,Blockader, Adrenergic beta-Receptor,Blockader, beta-Adrenergic Receptor,Blockaders, Adrenergic beta-Receptor,Blockaders, beta-Adrenergic Receptor,Blocker, beta-Adrenergic,Blockers, beta-Adrenergic,Blocking Agent, beta-Adrenergic,Blocking Agents, beta-Adrenergic,Receptor Blockader, beta-Adrenergic,Receptor Blockaders, beta-Adrenergic,beta Adrenergic Antagonist,beta Adrenergic Antagonists,beta Adrenergic Blocker,beta Adrenergic Blockers,beta Adrenergic Blocking Agent,beta Adrenergic Blocking Agents,beta Adrenergic Receptor Blockader,beta Adrenergic Receptor Blockaders,beta Adrenoceptor Antagonist,beta Adrenoceptor Antagonists,beta Blockers, Adrenergic,beta-Antagonist, Adrenergic,beta-Antagonists, Adrenergic,beta-Receptor Blockader, Adrenergic,beta-Receptor Blockaders, Adrenergic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000419 Albuminuria The presence of albumin in the urine, an indicator of KIDNEY DISEASES. Albuminurias

Related Publications

L M Ruilope, and J M Alcázar, and E Hernández, and M Praga, and V Lahera, and J L Rodicio
December 1987, Journal of clinical hypertension,
L M Ruilope, and J M Alcázar, and E Hernández, and M Praga, and V Lahera, and J L Rodicio
September 1983, The American journal of medicine,
L M Ruilope, and J M Alcázar, and E Hernández, and M Praga, and V Lahera, and J L Rodicio
June 1998, Hypertension research : official journal of the Japanese Society of Hypertension,
L M Ruilope, and J M Alcázar, and E Hernández, and M Praga, and V Lahera, and J L Rodicio
June 1993, Hypertension (Dallas, Tex. : 1979),
L M Ruilope, and J M Alcázar, and E Hernández, and M Praga, and V Lahera, and J L Rodicio
December 2014, Hypertension (Dallas, Tex. : 1979),
L M Ruilope, and J M Alcázar, and E Hernández, and M Praga, and V Lahera, and J L Rodicio
November 1992, The American journal of medicine,
L M Ruilope, and J M Alcázar, and E Hernández, and M Praga, and V Lahera, and J L Rodicio
September 1967, Die Medizinische Welt,
L M Ruilope, and J M Alcázar, and E Hernández, and M Praga, and V Lahera, and J L Rodicio
January 1997, Haemostasis,
L M Ruilope, and J M Alcázar, and E Hernández, and M Praga, and V Lahera, and J L Rodicio
January 2000, Le Journal medical libanais. The Lebanese medical journal,
L M Ruilope, and J M Alcázar, and E Hernández, and M Praga, and V Lahera, and J L Rodicio
May 1999, Current opinion in nephrology and hypertension,
Copied contents to your clipboard!